Show full item record

Permalink

http://hdl.handle.net/10138/194786

Citation

Eldfors , S , Kuusanmäki , H , Kontro , M , Majumder , M M , Parsons , A , Edgren , H , Pemovska , T , Kallioniemi , O , Wennerberg , K , Gökbuget , N , Burmeister , T , Porkka , K & Heckman , C A 2017 , ' Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia ' , Leukemia , vol. 31 , no. 1 , pp. 51-57 . https://doi.org/10.1038/leu.2016.202

Title:	Idelalisib sensitivity and mechanisms of disease progression in relapsed TCF3-PBX1 acute lymphoblastic leukemia
Author:	Eldfors, S.; Kuusanmäki, H.; Kontro, M.; Majumder, M. M.; Parsons, Alun; Edgren, H.; Pemovska, T.; Kallioniemi, O.; Wennerberg, K.; Gökbuget, N.; Burmeister, T.; Porkka, K.; Heckman, C. A.
Contributor organization:	Institute for Molecular Medicine Finland Clinicum Hematologian yksikkö Department of Oncology Department of Medicine Olli-Pekka Kallioniemi / Principal Investigator Krister Wennerberg / Principal Investigator HUS Comprehensive Cancer Center Precision Systems Medicine
Date:	2017
Language:	eng
Number of pages:	7
Belongs to series:	Leukemia
ISSN:	0887-6924
DOI:	https://doi.org/10.1038/leu.2016.202
URI:	http://hdl.handle.net/10138/194786
Subject:	3122 Cancers
Peer reviewed:	Yes
Rights:	cc_by_nc_sa
Usage restriction:	openAccess
Self-archived version:	publishedVersion



Files in this item

Total number of downloads: Loading...

Files	Size	Format	View
leu2016202a.pdf	1.450Mb	PDF	View/Open

This item appears in the following Collection(s)

• Articles from TUHAT CRIS [46467]
  

Show full item record